Robert D. Allen III, Chief Scientific Officer at Invivyd, Inc. (IVVD), sold 75,162 shares at $1.54 ($117K) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Open-market sale of $117k IVVD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.54 | 18,189 | $28K | 23.9% |
| 2 | $1.54 | 18,189 | $28K | 23.9% |
| 3 | $1.58 | 19,392 | $31K | 26.1% |
| 4 | $1.58 | 19,392 | $31K | 26.1% |
| Total | $1.56 avg | 75,162 | $117K | 100% |
| Filing → |